Titian is delighted to announce that Battery Ventures - a technology-focused global investment firm with expertise in life science - has made a significant majority investment in Titian. We look forward to future development and growth together.
The deal will fuel continued growth at the U.K.-based, sample-management software company, which improves research processes for critical biotech, pharmaceutical and academic organisations.
Read Battery Ventures full announcement here.
Titian’s founder, Edmund Wilson, retains a meaningful ownership stake in the company and will remain closely involved in leading the business going forward.
“Titian has been on a solid growth trajectory of late,” Wilson said. “But our new partnership with Battery represents a key inflection point for the company that should allow us to scale even further, in part by tapping Battery’s industry expertise, network and market savvy. With Battery’s help, Titian can better capitalise on the exciting growth opportunities we see ahead in the sample management sector.”
Titian Software was founded in 1999 and specialized in sample management software and consultancy services. Its Mosaic platform helped pharmaceutical, biotechnology and academic organizations improve sample management, automation and laboratory efficiency.
Today, Mosaic is part of Cenevo's connected laboratory platform portfolio.
Battery partners with exceptional founders and management teams developing category-defining businesses in markets including software and services, enterprise infrastructure, online marketplaces, healthcare IT and industrial technology. Founded in 1983, the firm backs companies at all stages, ranging from seed and early to growth and buyout, and invests globally from six strategic locations: Boston; San Francisco and Menlo Park, Calif.; Tel Aviv; London; and New York.
Follow the firm on Twitter @BatteryVentures, visit our website at www.battery.com and find a full list of Battery’s portfolio companies here.
Contacts
Rebecca Buckman
becky@battery.com
+1 650-292-2077